Answers are grounded in this paper and cite their sources.
The role of multimodality therapy in the treatment of oesophageal cancer has been extensively investigated in many longitudinal studies and randomized trials. Despite some promising results, no clear beneficial evidence has consistently been produced. At present it cannot be routinely recommended outside the context of controlled clinical trials.
No takes yet. Share an insight, caveat, or question.
Blazeby et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: